Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Evaluating Relapses in Central Nervous System in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemotherapy With or Without CNS Prophylaxis. Multicentric, Prospective, Randomized Phase III Study

NCT02777736 is registered in ClinicalTrials.gov with Czech Lymphoma Study Group as lead sponsor.

NCT NCT02777736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02777736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Evaluating Relapses in Central Nervous System in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemotherapy With or Without CNS Prophylaxis. Multicentric, Prospective, Randomized Phase III Study
Lead sponsor
Czech Lymphoma Study Group
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2015
Completion date
December 31, 2019
Enrollment
500 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell lymphoma